DSK Legal advised HealthQuad Fund II (“HealthQuad”) in relation to its primary and secondary investment in the Series A funding round of GoApptiv Private Limited (“Company”) along with Cipla Limited (“Cipla”) as a co-investor, wherein Cipla is an existing investor in the Company.
The Company is involved in the ‘HealthTech’ space and is engaged in the business of providing end-to-end business services to healthcare companies for improving the reach of their products to different geo market segments. The Company’s “smart-shared platforms” aims at providing agile market access, optimize patient experiences, deliver organizational growth, and empowering every stakeholder in the healthcare ecosystem.
DSK Legal advised HealthQuad on: (a) conducting the legal due diligence on the Company; and (b) drafting, negotiating, and finalizing the transaction documents in relation to HealthQuad’s primary and secondary investment in the Company.
The DSK Legal team representing HealthQuad Fund II on the Transaction comprised of Rishi Anand (Partner), Nakul Batra (Associate Partner), Shreya Singh (Associate), and Snigdha Prakash (Associate).
Cipla Limited was represented by its in-house legal counsels.
GoApptiv Private Limited was represented by Malvi Ranchoddas & Co.